ArticleJournal of the American College of Cardiology2014

Reply: limits of Mendelian randomization analyses in selection of secretory phospholipase A2-IIA as a valid therapeutic target for prevention of cardiovascular disease.

Michael V Holmes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.